That and your child like propensity for saying things like "poison jab".
Does the truth bother you? You guys like indictments and special counsels and Grand Jury reports...
Here's an excerpt from the Florida Grand Jury's report on Covid-19 and the "vaccines"
To see the truth of this, one needs look no further than the COVID-19 vaccines, all three of which were associated with safety issues necessitating FDA intervention. Janssen's AD26.COV2.S vaccine was granted Emergency Use Authorization on February 27, 2021, but was subsequently connected via pharmacovigilance to a rare event known as cerebral venous sinus -60-thrombosis. This SAE, which-as of April 2021-had been reported just six times after the administration of 6.8 million doses of AD26.COV2.S, was much too rare to have been seen in Janssen's 43,000 clinical trial participants. Once the signal was uncovered, the FDA and CDC promptly issued a joint statement recommending a "pause" in the marketing of AD26.COV2.S and informing the public of the SAE's existence and its tendency to occur in women-to that point, exclusively in women aged 18-48. The FDA also promptly commenced an emergency meeting of the ACIP to decide the best way forward. The ACIP examined the available data and chose to reaffirm its prior recommendation.
The marketing of AD26.COV2.S resumed with a warning regarding the "danger of rare blood clots after vaccination." In July of 2021, AD26.COV2.S
was associated with a second SAE, Guillain-Barre syndrome. This time, pharmacovigilance uncovered 100 preliminary reports-including one death-from a denominator of approximately 12.5 million administered doses. After examining the issue, the FDA announced "revisions to the vaccine recipient and vaccination provider fact sheets for the Janssen (Janssen) COVID-19 Vaccine to include information pertaining to an observed increased risk of Guillain-Barre Syndrome (GBS) following vaccination." Janssen's vaccine may have been the first to uncover unexpected safety events via pharmacovigilance,
but Pfizer's BNT162b2 and Moderna's MRNA-1273 were not far behind. In July of 2021, both vaccines were formally associated by the ACIP with rare instances of myocarditis and pericarditis (which we will explore in detail below). This serves to underscore the central thesis of the 2017 research study: The discovery of new SAEs after pharmacovigilance of biologics-including vaccines-that have already been found to be "safe and effective" by the FDA is unfortunate; to some extent, it is unavoidable, but it is not uncommon. Ordinarily, post-approval pharmacovigilance will have two primary dimensions: (1) A set of required "postmarketing studies," which often involve specific questions or issues that arise from either the clinical trials or from some prior form of licensure (like an EUA); and (2) a more generalized obligation for a sponsor to conduct "postmarketing surveillance," gathering outcome data from a variety of sources to develop a robust safety profile on its product and uncover infrequent safety events that may represent significant health risks.
To make this easy:
Pharma admits to these: Blood Clots, Guillain-Barre, myocarditis and pericarditis.
If I were to inject you with something like a chemical, and the result is blood clots, or GBS, or myocarditis, would you say that I poisoned you?